Creative Planning’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,301
Closed -$56K 4804
2015
Q3
$56K Buy
+1,301
New +$54.9K ﹤0.01% 1968
2015
Q2
Sell
-1,250
Closed -$48K 3970
2015
Q1
$48K Sell
1,250
-3,098
-71% -$119K ﹤0.01% 2065
2014
Q4
$146K Sell
4,348
-3,358
-44% -$119K ﹤0.01% 1327
2014
Q3
$270K Sell
7,706
-4,142
-35% -$142K ﹤0.01% 920
2014
Q2
$389K Buy
11,848
+10,698
+930% +$366K 0.01% 736
2014
Q1
$42K Buy
1,150
+600
+109% +$22K ﹤0.01% 1921
2013
Q4
$21K Buy
550
+250
+83% +$7.89K ﹤0.01% 2169
2013
Q3
$8K Sell
300
-650
-68% -$15.4K ﹤0.01% 2580
2013
Q2
$20K Buy
+950
New +$18.5K ﹤0.01% 1940

Other funds holding WX

Creative Planning's WX Position: Q4 2015 in Review

Creative Planning sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 1,301 shares — an estimated $56K sold.

Creative Planning first reported a position in WX in Q2 2013 and held it in 9 quarters. The position peaked at $389K in Q2 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Creative Planning reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Creative Planning sold 1,301 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $56K.
  • Creative Planning first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 9 quarters.
  • Creative Planning's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $389K in Q2 2014.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Creative Planning's 13F filing for Q4 2015, filed 11 Jan 2016.